Ozempic may be reshaping the brain, scientists say
Ground News • • general
Key Points:
- Researchers at the University of Colorado Anschutz Medical Campus have found that GLP-1 weight loss drugs like Ozempic may cause unusual changes in brain connectivity, particularly in adolescents and young women.
- These findings suggest that GLP-1 medications might be reshaping the nervous system, potentially affecting brain function beyond their role in weight loss.
- Scientists are investigating how these brain changes could influence addictive behaviors and age-related diseases such as Alzheimer's.
- The research highlights the need to better understand the broader neurological impacts of GLP-1 drugs, which are increasingly prescribed for weight management.